Back to Results

Evolent Health Inc (EVH)

Featured in Small-Cap Stocks

Evolent Health Inc. is a common stock listing on the NYSE under the ticker EVH. The company, through its subsidiary, provides specialty care management services in the United States with a focus on oncology, cardiology, and musculoskeletal care. It also operates an integrated value-based care platform used for health plan administration and management.

Beyond care management, Evolent offers administrative services that include health plan support, pharmacy benefits management, risk management, analytics and reporting, and leadership and management functions. Its technology portfolio includes Identifi, a proprietary system designed to collect and analyze data, manage care workflows, and support patient engagement. The company also provides Machinify Auth Intelligence, an artificial intelligence tool intended to assist nurses and physicians with the clinical review of prior authorization requests. Evolent Health was founded in 2011 and is headquartered in Arlington, Virginia.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-EVH
$6.81
18.1% Upside
Undervalued
$5.96
3.3% Upside
Fair
Fair
—
—
—
0.0%
August 6, 2026
-1.2x
1.6x
0.3x
667 M
1.497 B
59.6%
83.2%
0.5
-1.3%
-1.1%
Send a message
Valuation • Fair Value

Evolent Health Inc (NYSE-EVH) Fair Value by Valuation Model

Compare the primary fair value estimate for Evolent Health Inc (NYSE-EVH) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$6.81

Estimated upside of 18.1% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$5.85

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$7.77

Comparable-company valuation reference.

Analyst Price Target

$5.96

Analysts imply upside of 3.3%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Evolent Health Inc (NYSE-EVH) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Evolent Health Inc (NYSE-EVH)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

1.889 B

Current operating scale indicator.

Revenue Forecast

2.492 B

Forward revenue estimate.

EBITDA

74.355 M

Current operating profitability reference.

EBITDA Forecast

125.8 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Evolent Health Inc (NYSE-EVH) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Evolent Health Inc (NYSE-EVH)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-4.41

No elevated caution signal from this screen.

Altman Z-Score

0.5

Lower score that deserves closer risk review.

FCF / Net Income

-1.1%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Evolent Health Inc (NYSE-EVH). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Evolent Health Inc (NYSE-EVH)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 6, 2026

Days to Earnings

16

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

-1.3%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Evolent Health Inc (NYSE-EVH), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Evolent Health Inc (NYSE-EVH) Stock Forecast & Technical Outlook

Review Evolent Health Inc (NYSE-EVH) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Evolent Health Inc (NYSE-EVH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Evolent Health Inc (NYSE-EVH) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Evolent Health Inc (NYSE-EVH) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Evolent Health Inc (NYSE-EVH) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Evolent Health Inc (NYSE-EVH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Evolent Health Inc (NYSE-EVH)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Evolent Health Inc (NYSE-EVH) has a Strong Buy consensus, with 8 buy, 3 hold and 0 sell recommendations in the current data set.

Buy 8
Hold 3
Sell 0
FAQ • Fast Investor Answers

Evolent Health Inc (NYSE-EVH) Stock FAQ

Quick answers about Evolent Health Inc (NYSE-EVH) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$6.81
Estimated upside 18.1%
Valuation Rating
Undervalued
Estimated upside of 18.1%
Analyst Target
$5.96
Implied upside 3.3%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Evolent Health Inc (NYSE-EVH) is $6.81. This implies an estimated upside of 18.1% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 18.1% versus the current market price.

The available analyst price target for Evolent Health Inc (NYSE-EVH) is $5.96. The analyst target implies estimated upside of 3.3%.

The current financial health read for Evolent Health Inc (NYSE-EVH) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Evolent Health Inc (NYSE-EVH) is August 6, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Evolent Health Inc (NYSE-EVH) is -1.2x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Evolent Health Inc is 667 M.

The current enterprise value listed for Evolent Health Inc is 1.497 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Evolent Health Inc is NYSE-EVH, and the stock is listed on NYSE.

Evolent Health Inc (NYSE-EVH) is listed on NYSE.

The current debt-to-total-capital ratio listed for Evolent Health Inc is 59.6%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Evolent Health Inc is 83.2%. Free float helps investors understand how much of the share base is available for public trading.

Similar Health Care Technology Stocks on NYSE View more

Veeva Systems Inc Class A (VEEV) Veeva Systems Inc Class A (VEEV)
Doximity Inc (DOCS) Doximity Inc (DOCS)
Teladoc Inc (TDOC) Teladoc Inc (TDOC)
Phreesia Inc (PHR) Phreesia Inc (PHR)
Claritev Corp (CTEV) Claritev Corp (CTEV)
American Well Corp (AMWL) American Well Corp (AMWL)